(Q81364833)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15693021%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

title

Results of a Phase I study utilizing monocyte-derived dendritic cells pulsed with tumor RNA in children with Stage 4 neuroblastoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15693021%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

1 reference

1 reference

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15693021%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

author name string

Denise A Caruso

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15693021%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Lisa M Orme

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15693021%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Gerlinda M Amor

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15693021%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Alana M Neale

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15693021%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Peter Downie

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15693021%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Mimi L K Tang

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15693021%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

David M Ashley

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15693021%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

publication date

1 March 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15693021%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15693021%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

volume

103

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15693021%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15693021%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

page(s)

1280-1291

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15693021%20AND%20SRC:MED&resulttype=core&format=json

Neuroblastoma: biological insights into a clinical enigma

8 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20911

7 January 2021

DC-based cancer vaccines: lessons from clinical trials

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20911

7 January 2021

Differentiating agents in pediatric malignancies: retinoids in neuroblastoma.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20911

7 January 2021

Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20911

7 January 2021

Phase II trial of the anti-G(D2) monoclonal antibody 3F8 and granulocyte-macrophage colony-stimulating factor for neuroblastoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20911

7 January 2021

The bi-specific CD3 x NCAM antibody: a model to preactivate T cells prior to tumour cell lysis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20911

7 January 2021

Immune Deficiencies following Cancer Treatment in Children

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20911

7 January 2021

Recent advances in the biology of central nervous system tumors.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20911

7 January 2021

"In vitro" effect of interleukin-1 beta on human glioma cell lines: regulation of cell proliferation and IL-6 production

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20911

7 January 2021

Age, thymopoiesis, and CD4+ T-lymphocyte regeneration after intensive chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20911

7 January 2021

Phase II investigational window using carboplatin, iproplatin, ifosfamide, and epirubicin in children with untreated disseminated neuroblastoma: a Pediatric Oncology Group study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20911

7 January 2021

Circulating neuroblastoma cells detected by reverse transcriptase polymerase chain reaction for tyrosine hydroxylase mRNA are an independent poor prognostic indicator in stage 4 neuroblastoma in children over 1 year

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20911

7 January 2021

International criteria for diagnosis, staging, and response to treatment in patients with neuroblastoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20911

7 January 2021

Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20911

7 January 2021

Generation of mature dendritic cells from human blood. An improved method with special regard to clinical applicability

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20911

7 January 2021

Human Dendritic Cells Transfected with RNA Encoding Prostate-Specific Antigen Stimulate Prostate-Specific CTL Responses In Vitro

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20911

7 January 2021

Bone marrow-generated dendritic cells pulsed with tumor extracts or tumor RNA induce antitumor immunity against central nervous system tumors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20911

7 January 2021

DC therapy for metastatic melanoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20911

7 January 2021

The immune response to breast cancer, and the case for DC immunotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20911

7 January 2021

DC therapy for prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20911

7 January 2021

DC in multiple myeloma immunotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20911

7 January 2021

Dendritic cells: immunological sentinels with a central role in health and disease.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20911

7 January 2021

Identifiers

DOI

10.1002/CNCR.20911

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15693021%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

1 reference